At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4556 Gene Editing
已收盘 11-05 16:00:00 EST
406.07
+3.64
+0.90%
High406.66
Low378.22
Vol24.71M
Open392.54
D1 Closing402.43
Amplitude7.07%
Mkt Cap0.00
Tradable Cap0.00
Total Shares0.00
T/O217.99M
T/O Rate--
Tradable Shares0.00
P/B2.10217
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
Press Release: Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (ASH) Annual Meeting